PMDA
- Application: Symproic
- Local brand name: Symproic
- Status: approved
🇯🇵 Symproic in Japan
Symproic (NALDEMEDINE) regulatory status in Japan.
Marketing authorisation
Symproic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Symproic approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for Symproic in Japan?
Bdsi is the originator. The local marketing authorisation holder may differ — check the official source linked above.